Prostatis Group’s Vanguard Total International Stock ETF VXUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-6,996
Closed -$422K – 158
2024
Q2
$422K Buy
6,996
+21
+0.3% +$1.27K 0.15% 103
2024
Q1
$421K Buy
+6,975
New +$406K 0.16% 100
2023
Q3
– Sell
-7,804
Closed -$438K – 248
2023
Q2
$438K Sell
7,804
-49
-0.6% -$2.74K 0.2% 75
2023
Q1
$442K Sell
7,853
-126,074
-94% -$6.89M 0.23% 71
2022
Q4
$6.93M Buy
+133,927
New +$6.7M 4.23% 4
2021
Q2
– Sell
-8,113
Closed -$509K – 108
2021
Q1
$509K Sell
8,113
-86,391
-91% -$5.42M 0.4% 59
2020
Q4
$5.69M Buy
+94,504
New +$5.32M 4.76% 5

Other funds holding VXUS

Prostatis Group's VXUS Position: Q3 2024 in Review

Prostatis Group sold out of Vanguard Total International Stock ETF (VXUS) in Q3 2024, closing a stake of 6,996 shares — an estimated $422K sold.

Prostatis Group first reported a position in VXUS in Q4 2020 and held it in 7 quarters. The position peaked at $6.93M in Q4 2022. 1,187 funds tracked by Wall St. Rank hold VXUS as of Q3 2024.

  • Prostatis Group reported no remaining Vanguard Total International Stock ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 6,996 Vanguard Total International Stock ETF shares in Q3 2024, an estimated $422K.
  • Prostatis Group first reported a position in Vanguard Total International Stock ETF in Q4 2020 and held it in 7 quarters.
  • Prostatis Group's Vanguard Total International Stock ETF position peaked at $6.93M in Q4 2022.
  • 1,187 funds tracked by Wall St. Rank held Vanguard Total International Stock ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.